Use of Placental Growth Factor for Trisomy 21 Screening in Pregnancy: A Systematic Review
Background Prenatal serum screening is an important modality to screen for aneuploidy in pregnancy. The addition of placental growth factor (PLGF) to screen for trisomy 21 remains controversial. Objective To determine whether the addition of PLGF to combined serum aneuploidy screening improves detec...
Saved in:
Main Authors: | Ahmad Badeghiesh (Author), Alexander Volodarsky-Perel (Author), Ariane Lasry (Author), Robert Hemmings (Author), Yaron Gil (Author), Jacques Balayla (Author) |
---|---|
Format: | Book |
Published: |
Thieme Medical Publishers, Inc.,
2020-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bayes Theorem and Protopathic Bias: Methodological Concerns When Addressing the Impact of Fetal Heart Rate Patterns on the Cesarean Section Rate
by: Jacques Balayla, et al.
Published: (2020) -
Placental Abnormalities and Preeclampsia in Trisomy 13 Pregnancies
by: Chih-Ping Chen
Published: (2009) -
Prenatal diagnosis of maternal uniparental disomy 5 by amniocentesis associated with confined placental mosaicism for trisomy 5 and fetal trisomy 21 in a pregnancy
by: Chih-Ping Chen, et al.
Published: (2020) -
Discordant performances of non-invasive prenatal testing for foetal trisomy 21 screening in subgroups of pregnancies
by: Feng Suo, et al.
Published: (2023) -
Paternal age predicts live birth in women above 40 years of age undergoing in-vitro fertilization (IVF)
by: Guy Shrem, et al.
Published: (2021)